Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial

Goldschmidt, Hartmut; Mai, Elias K.; Duerig, Jan; Scheid, Christof; Weisel, Katja C.; Kunz, Christina; Bertsch, Uta; Hielscher, Thomas; Merz, Maximilian; Munder, Markus; Lindemann, Hans-Walter; Huegle-Doerr, Barbara; Tichy, Diana; Giesen, Nicola; Hose, Dirk; Seckinger, Anja; Huhn, Stefanie; Luntz, Steffen; Jauch, Anna; Elmaagacli, Ahmet; Rabold, Bernhard; Fuhrmann, Stephan; Brossart, Peter; Goerner, Martin; Bernhard, Helga; Hoffmann, Martin; Hillengass, Jens; Raab, Marc S.; Blau, Igor W.; Haenel, Mathias; Salwender, Hans J.

Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial

Autor(en):

Goldschmidt, Hartmut; Mai, Elias K.; Duerig, Jan; Scheid, Christof; Weisel, Katja C.; Kunz, Christina; Bertsch, Uta; Hielscher, Thomas; Merz, Maximilian; Munder, Markus; Lindemann, Hans-Walter; Huegle-Doerr, Barbara; Tichy, Diana; Giesen, Nicola; Hose, Dirk; Seckinger, Anja; Huhn, Stefanie; Luntz, Steffen; Jauch, Anna; Elmaagacli, Ahmet; Rabold, Bernhard; Fuhrmann, Stephan; Brossart, Peter; Goerner, Martin; Bernhard, Helga; Hoffmann, Martin; Hillengass, Jens; Raab, Marc S.; Blau, Igor W.; Haenel, Mathias; Salwender, Hans J.

Tübinger Autor(en):

Weisel, Katja

Erschienen in:

Leukemia (2020), Bd. 34, S. 1853-1865

Verlagsangabe:

Nature Publishing Group

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1038/s41375-020-0724-1

ISSN:

1476-5551